Bonvadis® features a unique formulation that creates an optimal wound bed conducing healing. Compared to conventional wound care solutions, it promotes a more streamlined pathway to wound closure, minimizing patient discomfort and downtime.
Bonvadis® supports wound bed preparation, optimal for wounds with delayed progression, persistent inflammatory wounds, infection-related chronic wound complexity, irregular wound geometry, or non-response to standard wound care. Early intervention by Bonvadis® in wound bed preparation result in optimal wound environment to avoid escalation to more complex advanced therapies such as negative pressure wound therapy, grafting, skin substitutes, or surgical options.
Bonvadis® Topical Matrix is formulated with an aqueous phase and hydrophobic-phase components to form a structured topical matrix that supports conformal contact with irregular wound surfaces during the application period. By creating an interface, Bonvadis® provides an optimal wound bed environment conducive to wound healing, including granulation, epithelization and tissue regeneration.
